PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3

Seung-Hoi Koo, Hiroaki Satoh, Stephan Herzig, Chih Hao Lee, Susan Hedrick, Rohit Kulkarni, Ronald M. Evans, Jerrold Olefsky, Marc Montminy

Research output: Contribution to journalArticle

419 Citations (Scopus)

Abstract

Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-γ coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-α, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-α. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.

Original languageEnglish
Pages (from-to)530-534
Number of pages5
JournalNature Medicine
Volume10
Issue number5
DOIs
Publication statusPublished - 2004 May 1
Externally publishedYes

Fingerprint

Peroxisome Proliferators
Liver
Insulin Resistance
Insulin
Cytoplasmic and Nuclear Receptors
Medical problems
Type 2 Diabetes Mellitus
Glucose
Protein-Serine-Threonine Kinases
Nuclear Receptor Coactivators
Muscle
Aptitude
Gluconeogenesis
Fatty Acids
Chemical activation
RNA Interference
Association reactions
RNA
Hypoglycemia
Oxidation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Koo, S-H., Satoh, H., Herzig, S., Lee, C. H., Hedrick, S., Kulkarni, R., ... Montminy, M. (2004). PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nature Medicine, 10(5), 530-534. https://doi.org/10.1038/nm1044

PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. / Koo, Seung-Hoi; Satoh, Hiroaki; Herzig, Stephan; Lee, Chih Hao; Hedrick, Susan; Kulkarni, Rohit; Evans, Ronald M.; Olefsky, Jerrold; Montminy, Marc.

In: Nature Medicine, Vol. 10, No. 5, 01.05.2004, p. 530-534.

Research output: Contribution to journalArticle

Koo, S-H, Satoh, H, Herzig, S, Lee, CH, Hedrick, S, Kulkarni, R, Evans, RM, Olefsky, J & Montminy, M 2004, 'PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3', Nature Medicine, vol. 10, no. 5, pp. 530-534. https://doi.org/10.1038/nm1044
Koo, Seung-Hoi ; Satoh, Hiroaki ; Herzig, Stephan ; Lee, Chih Hao ; Hedrick, Susan ; Kulkarni, Rohit ; Evans, Ronald M. ; Olefsky, Jerrold ; Montminy, Marc. / PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. In: Nature Medicine. 2004 ; Vol. 10, No. 5. pp. 530-534.
@article{98ebb53ebd5a43d7a92f1d9c0ce18a85,
title = "PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3",
abstract = "Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-γ coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-α, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-α. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.",
author = "Seung-Hoi Koo and Hiroaki Satoh and Stephan Herzig and Lee, {Chih Hao} and Susan Hedrick and Rohit Kulkarni and Evans, {Ronald M.} and Jerrold Olefsky and Marc Montminy",
year = "2004",
month = "5",
day = "1",
doi = "10.1038/nm1044",
language = "English",
volume = "10",
pages = "530--534",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3

AU - Koo, Seung-Hoi

AU - Satoh, Hiroaki

AU - Herzig, Stephan

AU - Lee, Chih Hao

AU - Hedrick, Susan

AU - Kulkarni, Rohit

AU - Evans, Ronald M.

AU - Olefsky, Jerrold

AU - Montminy, Marc

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-γ coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-α, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-α. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.

AB - Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-γ coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-α, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-α. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=2442701392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442701392&partnerID=8YFLogxK

U2 - 10.1038/nm1044

DO - 10.1038/nm1044

M3 - Article

VL - 10

SP - 530

EP - 534

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 5

ER -